Emerging triple agonist peptide (GLP-1 / GIP / Glucagon)
Very high interest in longevity + metabolic science.

Used for :

• Weight management
  

• Metabolic health
  

• Appetite regulation
  
  

What It Is:
A triple agonist peptide under investigation for metabolic pathway modulation.

Research Focus

• GLP-1 receptor studies
  

• Appetite signaling research
  

• Metabolic health pathways
  
  

Research Interest

• Obesity research labs
  

• Endocrinology departments
  

• Metabolic disease researchers

These compounds are intended solely for laboratory and scientific research. They are not approved for human or veterinary use and are not intended for diagnosis, treatment, or prevention of any disease.